20 units of semaglutide is how many mg — and why the conversion matters

How does the units-to-mg conversion actually work for semaglutide?

The unit system originates from insulin dosing. A U-100 insulin syringe holds 100 units per millilitre of liquid, and each unit therefore equals 0.01 ml. When semaglutide is prepared as a liquid for injection at a concentration of 1 mg per ml (a common compounded concentration) those units translate directly into milligrams: 10 units = 0.1 mg, 20 units = 0.2 mg, 50 units = 0.5 mg, and so on.

That arithmetic is internally consistent, but it only holds at that specific concentration. If a vial is prepared at a different strength (say 2 mg per ml or 5 mg per ml) the same 20 units on the syringe would contain 0.4 mg or 1.0 mg respectively. This is where conversion questions can become genuinely risky: the milligram content of any syringe pull depends entirely on the concentration of the liquid in the vial, which is not always labelled prominently or checked carefully. Our detailed look at how semaglutide doses map to units sets out the full concentration table for anyone who needs to understand this in more depth.

For context, the NHS semaglutide medicines page describes Wegovy doses in milligrams only (not units) because the licensed product removes this calculation from the patient entirely. The pen is pre-set. You inject once a week and the correct dose is delivered without any measurement step.

What does 0.2 mg of semaglutide actually represent in the Wegovy dose schedule?

The licensed Wegovy titration schedule for weight management starts at 0.25 mg weekly and rises through 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, with each step separated by roughly four weeks. The newer 7.2 mg pen, approved by the MHRA in April 2026, extends that ceiling further for eligible patients.

Against that backdrop, 0.2 mg sits below even the lowest licensed Wegovy starting dose. It is not a recognised step on the titration ladder. This matters if someone is attempting to recreate a Wegovy-equivalent dose using a vial and syringe, the fractions involved are small, the margin for measurement error is real, and the result may be either less or more than intended. You can see how the full Wegovy schedule is structured, including what the MHRA-approved 7.2 mg pen looks like in practice, on our Wegovy doses guide.

For anyone curious about a specific reference point: 0.25 mg equals 25 units in U-100 terms; 2.4 mg equals 240 units. The numbers are clean multiples, but they are rarely useful in practice because the licensed product bypasses them entirely. Understanding what 2.4 mg of Wegovy equates to in units is covered separately if that comparison is useful to you.

Why are patients searching for unit conversions, and what does that signal?

The honest answer is that most people asking this question have encountered semaglutide sold in vial form, often described as "compounded" or "research-grade", typically through online sellers or social media channels. Vials require a syringe and a conversion calculation; pre-filled pens do not. So if the conversion is the question, the product is usually not a licensed one.

The MHRA has warned clearly and repeatedly that unlicensed semaglutide products (including counterfeit pens and compounded vials sold without a prescription) pose real clinical risks. Concentration errors, contamination, and dosing uncertainty are documented concerns, not theoretical ones. Large enforcement operations in 2024 and 2025 seized significant volumes of illegally traded weight-loss medicines from UK distribution networks. If you are trying to work out how many units to draw up, it is worth asking whether the source of the product is one you can verify on the GPhC pharmacy register.

The licensed alternative is straightforward: a pre-filled Wegovy pen, dispensed following a clinical assessment, with no unit calculation required. Our Wegovy overview explains what the licensed treatment involves and who it is suitable for. For those who want to understand how the cost of private treatment fits together, our guide to Wegovy pricing in the UK covers what a legitimate private prescription typically includes.

Is there ever a legitimate reason to measure semaglutide in units?

Occasionally, yes, in a clinical or compounding pharmacy setting where a pharmacist is preparing a formulation and cross-checking concentration. But that is a professional context with analytical oversight, not a bedside calculation. For patients, the short answer is no: neither Wegovy nor Ozempic (the diabetes-licensed semaglutide) requires patients to handle a syringe or draw a volume. The dose is fixed inside the pen.

If you have been prescribed Wegovy and you are uncertain about your current dose or the next titration step, the right move is to contact your prescriber. Adjusting based on a unit conversion you have found online (even a mathematically correct one) bypasses the clinical judgement that makes dose increases safe. A quick habit worth building: before each weekly injection, check the dose printed on the label of your pen against what your prescriber told you to expect at this stage of treatment. It takes under a minute and catches any dispensing discrepancy before you inject. Further detail on converting a specific reference dose is also available in our companion page covering what 40 units of semaglutide equates to in mg.

Semaglutide is a prescription-only medicine. A prescriber reviews your full clinical picture before recommending a dose, not a conversion chart. If you would like to explore whether Wegovy is appropriate for you, speaking to a clinician is the right starting point.